All In Biotech

Drug Trial Radar · NCT07441642

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

A Randomized, Double Masked, Placebo-controlled, Multicenter, Dose-range Finding Study to Assess the Efficacy and Safety of FWY003 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 272 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

272

Planned (sponsor's estimate)

Start

Mar 9, 2026

Primary completion

Aug 21, 2029

Study completion Aug 22, 2029

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Mar 2, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Conditions

  • Geographic Atrophy Secondary to Age-related Macular Degeneration

Interventions

  • FWY003Drug

    FWY003 arm participants will receive a specific dose of FWY003

  • PlaceboDrug

    Placebo arm participants will receive placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of geographic atrophy (GA) lesion area in the study eyeTime frame: From Baseline to Month 18

Locations

65 sites in 19 countries. Site status is shown where the registry gives one.

  • Salehi Retina Institute

    Huntington Beach, California · Recruiting

  • Retinal Consultants Medical Group Inc

    Sacramento, California · Recruiting

  • California Retina Consultants

    Santa Barbara, California · Recruiting

  • Advanced Research LLC

    Boynton Beach, Florida · Recruiting

  • Advanced Research LLC

    Deerfield Beach, Florida · Recruiting

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida · Recruiting

  • Retina Associates New Orleans

    Metairie, Louisiana · Recruiting

  • Opthamalic Consultants of Boston

    Boston, Massachusetts · Recruiting

  • NJ Retina

    Toms River, New Jersey · Recruiting

  • New York Eye and Ear Infirmary of Mount Sinai

    New York, New York · Recruiting

  • Columbia University Medical Center

    New York, New York · Recruiting

  • Erie Retina Research LLC

    Erie, Pennsylvania · Recruiting

  • Mid Atlantic Retina

    Philadelphia, Pennsylvania · Recruiting

  • Retina Consultants TX Rsrch Ctr

    Bellaire, Texas · Recruiting

  • Retina Consultants of Houston PA

    Houston, Texas · Recruiting

  • Retina Consultants of Texas

    Katy, Texas · Recruiting

  • Novartis Investigative Site

    Caba, Argentina · Recruiting

  • Novartis Investigative Site

    CABA, Argentina · Recruiting

  • Novartis Investigative Site

    Rosario, De Santa Fe, Argentina · Recruiting

  • Novartis Investigative Site

    Albury, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    Parramatta, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    Strathfield, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    East Melbourne, Victoria, Australia · Recruiting

  • Novartis Investigative Site

    Serra, Espírito Santo, Brazil · Recruiting

  • Novartis Investigative Site

    Blumenau, Santa Catarina, Brazil · Recruiting

  • Novartis Investigative Site

    Sofia, Bulgaria · Recruiting

  • Novartis Investigative Site

    London, Ontario, Canada · Recruiting

  • Novartis Investigative Site

    Ottawa, Ontario, Canada · Recruiting

  • Novartis Investigative Site

    Shanghai, China · Recruiting

  • Novartis Investigative Site

    Medellín, Antioquia, Colombia · Recruiting

  • Novartis Investigative Site

    Barranquilla, Atlántico, Colombia · Recruiting

  • Novartis Investigative Site

    Prague, Czechia · Recruiting

  • Novartis Investigative Site

    Prague, Czechia · Recruiting

  • Novartis Investigative Site

    Créteil, France · Recruiting

  • Novartis Investigative Site

    Dijon, France · Recruiting

  • Novartis Investigative Site

    Paris, France · Recruiting

  • Novartis Investigative Site

    Lyon, Rhone, France · Recruiting

  • Novartis Investigative Site

    Bonn, Germany · Recruiting

  • Novartis Investigative Site

    Münster, Germany · Recruiting

  • Novartis Investigative Site

    Tübingen, Germany · Recruiting

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.